A new MMWR summarizes the decision of the Advisory Committee on Immunization Practices (ACIP) to resume Johnson & Johnson COVID-19 vaccination.
FDA has added a warning to the vaccine EUA and factsheets, and patient education about this risk should continue. Additionally, FDA has published an updated FAQ about the Johnson & Johnson vaccine. For more, see ASTHO’s updated brief on ACIP’s decision to lift the recommended pause on the Johnson & Johnson vaccine.
